Nader is not able to read the future. The fda requested info, so he gave it. Case closed. Why bring up information that has already been CLEARLY answered by Cytodyn’s PR.
“...today further clarified the status of the Company’s submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for leronlimab as a combination therapy with HAART for highly treatment experienced HIV patients, filed on April 27, 2020 with the FDA. “
And I suspect they received legal advice to simply not comment further on the “status” the subject matter regardless in the presser for obvious reasons. People forget but sometimes no news, is good news.
SP Seems destined to move upwards regardless of the short attempts. Strong science leaves very little for the short gang to manufacture that creates the kind of fear needed to create a sell off.
It’s obvious that there is a whole lot of investors that believe in the science not to mention all the docs and hospitals that are on board.